4.2 Article

Neurological Presentations in Patients with COVID-19 in Cytokine Storm

Related references

Note: Only part of the references are listed.
Article Neurosciences

Altered mental status in 71 deaths due to COVID-19

Brad Tyson et al.

Summary: This study investigates the occurrence of neurologic symptoms in COVID-19 deaths, particularly altered mental status. The study finds that neurologic symptoms, especially altered mental status, are highly common in COVID-19 patients with a high risk of mortality. Comorbidities such as hypertension, cardiovascular disease, and dementia are associated with death due to COVID-19.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2022)

Review Pharmacology & Pharmacy

Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection

Jennis Meanwatthana et al.

Summary: IL-6 antagonists may offer clinical advantages in severe COVID-19 by reducing inflammation and decreasing the need for invasive ventilation support. However, their use also carries safety risks such as bone marrow suppression. Robust clinical evidence is needed to confirm the efficacy and safety of IL-6 antagonists.

JOURNAL OF PHARMACY PRACTICE (2022)

Article Rheumatology

Preliminary predictive criteria for COVID-19 cytokine storm

Roberto Caricchio et al.

Summary: Researchers developed predictive criteria for COVID-19-associated cytokine storm (CS) and proposed new early predictive criteria to identify CS occurring in patients with COVID-19, which can determine the need for early therapeutic regimen and potentially reduce mortality.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Review Hematology

The looming storm: Blood and cytokines in COVID-19

Supreet Kaur et al.

Summary: COVID-19, caused by the novel coronavirus, has led to a global pandemic with high mortality rates attributed mainly to multiple organ dysfunction such as respiratory failure, sepsis, cardiac failure, kidney injury, or coagulopathy. Hematological abnormalities, elevated cytokines, and thrombotic complications are crucial prognostic factors for worse outcomes in COVID-19 patients. Understanding the pathophysiology of these hematological abnormalities is essential for effective management and treatment strategies.

BLOOD REVIEWS (2021)

Article Clinical Neurology

A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City

Jennifer A. Frontera et al.

Summary: This study found that 13.5% of COVID-19 patients developed new neurologic disorders, which were associated with increased risk of in-hospital mortality and decreased likelihood of discharge home.

NEUROLOGY (2021)

Editorial Material Rheumatology

COVID-19 cytokine storm: what is in a name?

Peter A. Nigrovic

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses

Andrea Pilotto et al.

Summary: SARS-CoV-2-related encephalitis is associated with prominent glial activation and neuroinflammatory markers, with neuronal markers increased only in severe cases. The pattern of CSF alterations suggests cytokine-release syndrome as the main inflammatory mechanism of SARS-CoV-2-related encephalitis.

CLINICAL INFECTIOUS DISEASES (2021)

Article Clinical Neurology

Neurological manifestations of COVID-19 in confirmed and probable cases: A descriptive study from a large tertiary care center

Hatice Yuksel et al.

Summary: This study identified altered mental status (AMS) as the most common neurological finding in COVID-19 patients, with pre-existing neurological diseases being a risk factor for AMS and significantly higher mortality rates associated with AMS. Patients with seizure attacks also had elevated mortality rates.

JOURNAL OF CLINICAL NEUROSCIENCE (2021)

Review Biochemistry & Molecular Biology

Cytokine storm induced by SARS-CoV-2 infection: The spectrum of its neurological manifestations

Parisorn Thepmankorn et al.

Summary: COVID-19 caused by SARS-CoV-2 can lead to a hyperinflammatory state known as cytokine storm, especially in severe patients. In addition to respiratory complications, neurological issues have also been reported in COVID-19 patients. Understanding and targeting aberrant cytokine levels, particularly in those with neurological symptoms, may be crucial in effective treatment and management of the disease.

CYTOKINE (2021)

Article Infectious Diseases

Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak

P. Sabaka et al.

Summary: This study explored the role of interleukin 6 (IL-6) as a predictor for severe disease during a COVID-19 outbreak in a long-term care facility in Slovakia. The concentration of IL-6 > 24 pg/mL at initial assessment was found to predict the development of hypoxemia requiring hospitalization with excellent sensitivity and good specificity.

BMC INFECTIOUS DISEASES (2021)

Review Multidisciplinary Sciences

A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic

Hyung-Jun Kim et al.

Summary: The mortality rates of COVID-19 vary globally, with different risk factors influencing critical outcomes such as sex, age, underlying medical conditions, symptoms, and laboratory findings. Regional studies suggest differences in the impact of respiratory and hepatic diseases, symptoms, and blood test results on critical outcomes between Asia, Europe, and North America.

SCIENTIFIC REPORTS (2021)

Review Clinical Neurology

Neurological Manifestations of COVID-19: A systematic review and current update

Abigail Whittaker et al.

ACTA NEUROLOGICA SCANDINAVICA (2020)

Article Clinical Neurology

COVID-19 is a Real Headache!

Hayrunnisa Bolay et al.

HEADACHE (2020)

Review Immunology

The many faces of the anti-COVID immune response

Santosha A. Vardhana et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Article Rheumatology

On the Alert for Cytokine Storm: Immunopathology in COVID-19

Lauren A. Henderson et al.

ARTHRITIS & RHEUMATOLOGY (2020)

Review Clinical Neurology

Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review

Muhammad Umer Ahmed et al.

FRONTIERS IN NEUROLOGY (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Multiorgan and Renal Tropism of SARS-CoV-2

Victor G. Puelles et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Clinical Neurology

Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline

Pranusha Pinna et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)

Review Biochemistry & Molecular Biology

Effects of COVID-19 on the Nervous System

Costantino Iadecola et al.

Review Clinical Neurology

COVID-19 and seizures: Is there a link?

Divya Vohora et al.

EPILEPSIA (2020)

Article Allergy

The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection

Ana Copaescu et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Review Cell Biology

COVID-19 and multiorgan failure: A narrative review on potential mechanisms

Tahmineh Mokhtari et al.

JOURNAL OF MOLECULAR HISTOLOGY (2020)

Review Immunology

Neurological consequences of COVID-19: what have we learned and where do we go from here?

Abbas Jarrahi et al.

JOURNAL OF NEUROINFLAMMATION (2020)

Review Immunology

Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation

Isabelle Amigues et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)

Review Medicine, General & Internal

Cytokine Storm

David C. Fajgenbaum et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)